Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
This study is currently recruiting participants.
Verified December 2013 by NeurAxon Inc.
Information provided by (Responsible Party):
First received: December 11, 2012
Last updated: December 31, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2013|
|Estimated Primary Completion Date:||December 2013 (Final data collection date for primary outcome measure)|